Pilot Study of Sodium-Glucose Cotransporter 2 Inhibitor Empagliflozin Shows Reduced Intrarenal Complement Activation in Patients With Diabetes and CKD
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-02-01
|
| Series: | Kidney International Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2468024924020357 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850127436589563904 |
|---|---|
| author | Mia Jensen Steffen F. Nielsen Steffen Thiel Søren W.K. Hansen Yaseelan Palarasah Per Svenningsen Jesper N. Bech Frank H. Mose Boye L. Jensen |
| author_facet | Mia Jensen Steffen F. Nielsen Steffen Thiel Søren W.K. Hansen Yaseelan Palarasah Per Svenningsen Jesper N. Bech Frank H. Mose Boye L. Jensen |
| author_sort | Mia Jensen |
| collection | DOAJ |
| format | Article |
| id | doaj-art-12273d144af445409f22e2beb3265c30 |
| institution | OA Journals |
| issn | 2468-0249 |
| language | English |
| publishDate | 2025-02-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Kidney International Reports |
| spelling | doaj-art-12273d144af445409f22e2beb3265c302025-08-20T02:33:40ZengElsevierKidney International Reports2468-02492025-02-0110259159510.1016/j.ekir.2024.11.014Pilot Study of Sodium-Glucose Cotransporter 2 Inhibitor Empagliflozin Shows Reduced Intrarenal Complement Activation in Patients With Diabetes and CKDMia Jensen0Steffen F. Nielsen1Steffen Thiel2Søren W.K. Hansen3Yaseelan Palarasah4Per Svenningsen5Jesper N. Bech6Frank H. Mose7Boye L. Jensen8Unit of Cardiovascular and Renal Research, Department of Molecular Medicine, University of Southern Denmark, Odense, Denmark; Correspondence: Mia Jensen, Department for Molecular Medicine, Unit for Cardiovascular and Renal Research, University of Southern Denmark, Campusvej 55, 5230 Odense M, Denmark.University Clinic in Nephrology and Hypertension, Gødstrup Hospital, Herning, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, DenmarkDepartment of Biomedicine, Aarhus University, Aarhus, DenmarkUnit of Cancer and Inflammation Research, Department of Molecular Medicine, University of Southern Denmark, Odense, DenmarkUnit of Cancer and Inflammation Research, Department of Molecular Medicine, University of Southern Denmark, Odense, DenmarkUnit of Cardiovascular and Renal Research, Department of Molecular Medicine, University of Southern Denmark, Odense, DenmarkUniversity Clinic in Nephrology and Hypertension, Gødstrup Hospital, Herning, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, DenmarkUniversity Clinic in Nephrology and Hypertension, Gødstrup Hospital, Herning, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, DenmarkUnit of Cardiovascular and Renal Research, Department of Molecular Medicine, University of Southern Denmark, Odense, Denmarkhttp://www.sciencedirect.com/science/article/pii/S2468024924020357kidney injurylectin cascadetype 2 diabetes mellitus |
| spellingShingle | Mia Jensen Steffen F. Nielsen Steffen Thiel Søren W.K. Hansen Yaseelan Palarasah Per Svenningsen Jesper N. Bech Frank H. Mose Boye L. Jensen Pilot Study of Sodium-Glucose Cotransporter 2 Inhibitor Empagliflozin Shows Reduced Intrarenal Complement Activation in Patients With Diabetes and CKD Kidney International Reports kidney injury lectin cascade type 2 diabetes mellitus |
| title | Pilot Study of Sodium-Glucose Cotransporter 2 Inhibitor Empagliflozin Shows Reduced Intrarenal Complement Activation in Patients With Diabetes and CKD |
| title_full | Pilot Study of Sodium-Glucose Cotransporter 2 Inhibitor Empagliflozin Shows Reduced Intrarenal Complement Activation in Patients With Diabetes and CKD |
| title_fullStr | Pilot Study of Sodium-Glucose Cotransporter 2 Inhibitor Empagliflozin Shows Reduced Intrarenal Complement Activation in Patients With Diabetes and CKD |
| title_full_unstemmed | Pilot Study of Sodium-Glucose Cotransporter 2 Inhibitor Empagliflozin Shows Reduced Intrarenal Complement Activation in Patients With Diabetes and CKD |
| title_short | Pilot Study of Sodium-Glucose Cotransporter 2 Inhibitor Empagliflozin Shows Reduced Intrarenal Complement Activation in Patients With Diabetes and CKD |
| title_sort | pilot study of sodium glucose cotransporter 2 inhibitor empagliflozin shows reduced intrarenal complement activation in patients with diabetes and ckd |
| topic | kidney injury lectin cascade type 2 diabetes mellitus |
| url | http://www.sciencedirect.com/science/article/pii/S2468024924020357 |
| work_keys_str_mv | AT miajensen pilotstudyofsodiumglucosecotransporter2inhibitorempagliflozinshowsreducedintrarenalcomplementactivationinpatientswithdiabetesandckd AT steffenfnielsen pilotstudyofsodiumglucosecotransporter2inhibitorempagliflozinshowsreducedintrarenalcomplementactivationinpatientswithdiabetesandckd AT steffenthiel pilotstudyofsodiumglucosecotransporter2inhibitorempagliflozinshowsreducedintrarenalcomplementactivationinpatientswithdiabetesandckd AT sørenwkhansen pilotstudyofsodiumglucosecotransporter2inhibitorempagliflozinshowsreducedintrarenalcomplementactivationinpatientswithdiabetesandckd AT yaseelanpalarasah pilotstudyofsodiumglucosecotransporter2inhibitorempagliflozinshowsreducedintrarenalcomplementactivationinpatientswithdiabetesandckd AT persvenningsen pilotstudyofsodiumglucosecotransporter2inhibitorempagliflozinshowsreducedintrarenalcomplementactivationinpatientswithdiabetesandckd AT jespernbech pilotstudyofsodiumglucosecotransporter2inhibitorempagliflozinshowsreducedintrarenalcomplementactivationinpatientswithdiabetesandckd AT frankhmose pilotstudyofsodiumglucosecotransporter2inhibitorempagliflozinshowsreducedintrarenalcomplementactivationinpatientswithdiabetesandckd AT boyeljensen pilotstudyofsodiumglucosecotransporter2inhibitorempagliflozinshowsreducedintrarenalcomplementactivationinpatientswithdiabetesandckd |